Chuck Wagner

Vice President, Market Access at Cormedix Inc.
  • Claim this Profile
Contact Information
us****@****om
(386) 825-5501
Location
New York City Metropolitan Area, US

Topline Score

Topline score feature will be out soon.

Bio

Generated by
Topline AI

You need to have a working account to view this content.
You need to have a working account to view this content.

Experience

    • United States
    • Pharmaceutical Manufacturing
    • 1 - 100 Employee
    • Vice President, Market Access
      • Feb 2020 - Present

    • VP – Senior Director Market Access | Consultant | Market Access Marketing & Reimbursement
      • Aug 2019 - Present

      Versatile and collaborative Market Access Executive with significant experience leading biotech and pharmaceutical brands to successful pre-launch, launch, and market outcomes.Key Competencies: ► Market Access: Payer Strategy | Value Proposition | Payer Contract Strategy | Contract Modeling & Negotiation | Payer Customer Reach | Pricing & Forecasting | 3PL & Support HUB Construction | Pre-Launch & Launch Plans► Sites of Care: Office | LTC/Sub-acute | Hospitals | Trade | VA/DoD► Therapeutic Areas: Oncology | CNS disorders | Hematology | Specialty Orphan Conditions | Ophthalmology | Neurology | Thyroid Conditions | Cardiovascular Conditions | Anti-Infectives | Auditory Disorders ► Leadership: Cross-functional Team Leadership | Team Building | Talent Acquisition | Leadership Development | Coaching & Mentoring | Training | P&L Management | Employee Engagement | Relationship Building

    • President
      • 2017 - 2019

      Privately held medical advertising agency with 12 employees; division of MJH Associates, with 400 employees. Hired to build and staff professional/payer marketing agency within established medical media company. Developed business plan and financial forecast, and defined target market and competitive differentiation. Partnered with entrepreneurial biotech clients in development of pre-launch and launch plans for oncology brands across professional and payer customers. Managed P&L and established standard operating procedures for division. ► Drove significant top line revenue within 19 months through business development efforts. Won business while competing against larger agencies by developing strong brand positioning and payer value propositions.► Recruited and developed team of 12 top medical communications experts (creative, strategy, and account).

    • President
      • 2013 - 2017

      Professional medical advertising agency with 100 employees serving clinical clients.Selected by CEO to orchestrate turnaround of division facing declining revenues and leadership challenges. Obtained in-depth therapeutic experience including CNS disorders, oncology and hematology, and specialty orphan conditions including hypoparathyroidism and ophthalmic disorders. Held full P&L responsibility for top line revenue and staff of 90. Served on leadership team for network contract negotiation strategic planning. ► Restored top-line revenue to network-leading margin performance within 12 months by developing strong market position and elite leadership team. Added new clients in oncology, ophthalmology and neurology.► Boosted employee engagement, achieving score of 4.28/5.0 and 88% “intent to stay” within 18 months (21% annual increase). Shared vision/mission and elevated work life balance.► Drove top-line revenue growth of >10% by leading spin-off of second, independent payer group, Entrée Health Princeton, while leading CDM Princeton. Mentored new leadership team.

    • United States
    • Advertising Services
    • 100 - 200 Employee
    • Managing Partner, Director of Client & Strategic Services
      • 2006 - 2016

      Medical advertising agency with 100 employees specializing in market access (patients, physicians, and payers).Recruited to launch market access agency from nascent payer marketing division. Assumed accountability for full P&L. Led teams in development of market access strategies including patient support HUBs. Grew staff to 100+ and developed future leaders.► Grew revenues four-fold within eight years with network-leading margins. Won new clients by communicating impactful clinical value propositions across all sites of care.

    • Executive Director, Managed Markets
      • 2001 - 2006

      Privately held start-up pharmaceutical company selling cardiovascular disease products, with 300 employees. Acquired by Glaxo.Led market access team of 25 covering account management, payer marketing, contracting strategy and contracting operations. Developed payer value propositions for portfolio brands, ensuring target access goals to hit both volume and margin targets. Directed cross-functional teams in brand marketing, finance, and regulatory/compliance. Built relationships with key opinion leaders in commercial, government, trade, and distribution markets.► Developed Part D portfolio pricing/forecasting model driving organizational contract strategy in commercial and government markets. ► Attained >85% nationwide favorable formulary position within six months for omega fatty acid Rx by using novel strategy to gain access to Part D accounts, leading to recognition in commercial markets. ► Assured broad market access at target margins for cardiovascular portfolio (statin, CCB, fenofibrate, and omega fatty acid Rx) by leading contracting strategy team.

    • Germany
    • Pharmaceutical Manufacturing
    • 700 & Above Employee
    • Senior Market Manager, Market Access
      • 2000 - 2001

      Coordinated professional and payer marketing teams. Established key operational relationships with payer opinion leaders and restructured and negotiated payer contracts. Payer strategy lead for global brand pre-launch planning. Coordinated professional and payer marketing teams. Established key operational relationships with payer opinion leaders and restructured and negotiated payer contracts. Payer strategy lead for global brand pre-launch planning.

    • Market Access & Sales
      • 1989 - 1999

      Led institutional marketing and contract strategy for anti-infective and cardiovascular portfolio. Launched novel contracting approach. Increased market share and obtained preferred formulary positioning. Top sales producer. Led institutional marketing and contract strategy for anti-infective and cardiovascular portfolio. Launched novel contracting approach. Increased market share and obtained preferred formulary positioning. Top sales producer.

Education

  • Towson University
    Master of Science - MS, Audiology
    -
  • Northeastern University
    Bachelor of Science - BS, Communication Sciences & Disorders
    -
  • Bradford College
    AA, Liberal Arts
    -

Community

You need to have a working account to view this content. Click here to join now